Case number 1:21-cv-01141
Astellas Pharma Inc. et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 19, 2022 | 14 | STIPULATION OF DISMISSAL. (See Stipulation for further details). (CASE CLOSED). Signed by Judge Joseph F. Bataillon on 12/19/2022. (twk) (Entered: 12/19/2022) (2) |
| Dec 9, 2022 | 13 | STIPULATION of Dismissal without prejudice by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 12/09/2022) (2) |
| Aug 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (10 in 1:21-cv-01141-JFB-CJB, 165 in 1:20-cv-01589-JFB-CJB) Stipulation To Forgo Answer of Appotex Inc. and Apotex Corp.. Ordered by Judge Christopher J. Burke on 8/26/2021. Associated Cases: 1:21-cv-01141-JFB-CJB, 1:20-cv-01589-JFB-CJB(dlb) |
| Aug 26, 2021 | N/A | Create Case Association (0) Docket Text: Case associated with lead case 20-1589. Ordered by Judge Christopher J. Burke on 8/26/2021. (dlb) |
| Aug 25, 2021 | 12 | Order (3) Docket Text: ORDER granting [166] STIPULATION and Proposed Order Regarding Case Consolidation by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. The LEAD Case shall be 20-1589-JFB-CJB and all future docket entries for these cases shall be made in the lead case only. Signed by Judge Joseph F. Bataillon on 8/25/2021. Associated Cases: 1:20-cv-01589-JFB-CJB, 1:21-cv-01141-JFB-CJB(nmg) |
| Aug 24, 2021 | 8 | Affidavit of Service (2) Docket Text: AFFIDAVIT of Service for Complaint and Related Papers served on Apotex, Inc. on August 23, 2021, filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) |
| Aug 24, 2021 | 9 | Affidavit of Service (2) Docket Text: AFFIDAVIT of Service for Complaint and Related Papers served on Apotex Corp. on August 23, 2021, filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) |
| Aug 24, 2021 | 10 | Stipulation (3) Docket Text: STIPULATION To Forgo Answer of Appotex Inc. and Apotex Corp. by Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Ireland Co., Ltd.. (Joyce, Alexandra) |
| Aug 24, 2021 | 11 | Stipulation (3) Docket Text: STIPULATION and Proposed Order Regarding Case Consolidation by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) |
| Aug 11, 2021 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) |
| Aug 9, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to prior related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) |
| Aug 9, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Christopher J. Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 08/09/2021. (AEV) |
| Aug 5, 2021 | 1 | Main Document (10) Docket Text: COMPLAINT filed against Apotex Corp. and Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3673356.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(srs) |
| Aug 5, 2021 | 1 | Exhibit A (19) |
| Aug 5, 2021 | 1 | Civil Cover Sheet (2) |
| Aug 5, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Aug 5, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/23/2021. Date of Expiration of Patent: 9/28/2029.Thirty Month Stay Deadline: 12/23/2023. (srs) |
| Aug 5, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,842,780. (srs) |
| Aug 5, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd.; Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Corporate Parent Astellas Pharma Inc. for Astellas B.V. and Astellas US Holdings, Inc., Inc. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc.. (srs) |
| Aug 5, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (srs) |
| Aug 5, 2021 | 1 | Complaint* (1) |
